SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Associations between early-life exposures and the infant skin microbiome

Broderick, C; Poulsen, CS; Hjelmsø, MH; Marrs, T; Radulovic, S; Logan, K; Li, X; Wu, Z; Sørensen, SJ; Ezzamouri, B; et al. Broderick, C; Poulsen, CS; Hjelmsø, MH; Marrs, T; Radulovic, S; Logan, K; Li, X; Wu, Z; Sørensen, SJ; Ezzamouri, B; Alexander, H; Fyhrquist, N; Alenius, H; Bhattacharyya, M; Neumann, AU; Lack, G; Perkin, M; Bønnelykke, K; Stokholm, J; Flohr, C (2026) Associations between early-life exposures and the infant skin microbiome. British Journal of Dermatology. ljaf524. ISSN 0007-0963 https://doi.org/10.1093/bjd/ljaf524
SGUL Authors: Perkin, Michael Richard

[img] PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (2MB)
[img] Microsoft Word (.docx) (Supplementary data) Supporting information
Download (20MB)

Abstract

Background Factors influencing the early-life skin microbiome, and the association with atopic dermatitis (AD), are relatively unexplored. Objective To evaluate associations with the infant skin microbiome during the first year of life. Methods 3-month-old infants from the Enquiring About Tolerance (EAT) birth cohort were examined for AD at enrolment, 1 and 3 years of age. Parent-completed questionnaires, trans-epidermal water loss (TEWL), and filaggrin mutation status were evaluated. Bacterial swabs were collected from the elbow crease and volar forearm in 148 infants at 3 months and 1 year of age, and the microbiome composition was characterized using 16S rRNA gene sequencing (V3-V4 region). Results Shannon diversity was significantly higher at the forearm compared to the elbow. Staphylococcus, Acinetobacter, and Streptococcus were the most abundant genera across time and body-site. Microbiome community composition was primarily associated with body-site and age (p≤0.001, both). Other significant associations were found with ethnicity (p=0.009), filaggrin status (p≤0.001), urban-vs-rural residence (p=0.005), older siblings (p=0.041), bath product usage at 3 months (p=0.011), but not with pets (p=0.159), systemic antibiotics (p=0.27) nor with bathing frequency (p=0.109). The microbiome was associated with elevated TEWL (3-months p=0.004, 1-year p≤0.001) and with concurrent AD (3-months p=0.027, 1-year p≤0.001). Streptococcus parasanguinis was significantly less abundant in non-lesional skin of infants with AD at 3 months. Conclusion In addition to age and body-site, the infant skin microbiome is associated with heritable factors, the home environment, hygiene practices, and with the presence of AD.

Item Type: Article
Additional Information: © The Author(s) 2026. Published by Oxford University Press on behalf of British Association of Dermatologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: British Journal of Dermatology
ISSN: 0007-0963
Language: en
Media of Output: Print-Electronic
Related URLs:
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
T07051Food Standards Agencyhttp://dx.doi.org/10.13039/501100000354
MC_G1001205Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
NIHRCS/01/2008/009National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
821511Innovative Medicines Initiativehttps://doi.org/10.13039/501100010767
PubMed ID: 41542943
Dates:
Date Event
2026-01-16 Published Online
2025-12-13 Accepted
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/118464
Publisher's version: https://doi.org/10.1093/bjd/ljaf524

Actions (login required)

Edit Item Edit Item